Literature DB >> 17336741

Management of adult growth hormone deficiency.

Gudmundur Johannsson1.   

Abstract

The management of adults who have severe growth hormone deficiency (GHD) includes its recognition in susceptible patients, including all subjects who have any form of hypothalamic pituitary disorder. This article also focuses on the overall management of adults who have hypopituitarism and severe GHD. This includes aspects of diagnosis and management of growth hormone replacement therapy and the current status of its long-term safety. Some special circumstances, including the pregnant woman who has hypopituitarism, are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336741     DOI: 10.1016/j.ecl.2006.11.012

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  7 in total

Review 1.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

2.  Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

Authors:  Amir H Hamrahian; Kevin C J Yuen; Murray B Gordon; Karen J Pulaski-Liebert; James Bena; Beverly M K Biller
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

Review 3.  How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?

Authors:  Anna Pawlikowska-Haddal; Pinchas Cohen; David M Cook
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 4.  The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.

Authors:  Darlene E Berryman; Camilla A M Glad; Edward O List; Gudmundur Johannsson
Journal:  Nat Rev Endocrinol       Date:  2013-04-09       Impact factor: 43.330

5.  Successful Pregnancies and Deliveries in a Patient With Evolving Hypopituitarism due to Pituitary Stalk Transection Syndrome: Role of Growth Hormone Replacement.

Authors:  Miyako Yoshizawa; Yasuhiko Ieki; Eisuke Takazakura; Kaori Fukuta; Takao Hidaka; Takanobu Wakasugi; Akira Shimatsu
Journal:  Intern Med       Date:  2017-03-01       Impact factor: 1.271

Review 6.  LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity.

Authors:  Xuehan Lu; Lili Huang; Zhengxiang Huang; Dandan Feng; Richard J Clark; Chen Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-24       Impact factor: 5.555

7.  Early overnutrition sensitizes the growth hormone axis to the impact of diet-induced obesity via sex-divergent mechanisms.

Authors:  M A Sanchez-Garrido; F Ruiz-Pino; A I Pozo-Salas; J M Castellano; M J Vazquez; R M Luque; M Tena-Sempere
Journal:  Sci Rep       Date:  2020-08-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.